Views & Analysis Tunnah’s musings: Hope over hype for pharma in patient centr... Three areas where the pharma industry will advance in 2017 as it looks beyond the hype.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
